Tobramycin Via pharma

Medicinal product

(Invented) name

Tobramycin Via pharma

Active substance (s)

Tobramicinas

Strength

300 mg/5 ml

Pharmaceutical form

purškiamasis įkvepiamasis tirpalas

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01GB01, Tobramycin

Marketing authorisation holder

UAB Via pharma, Lietuva

Date of authorisation

2016-06-17

Date of renewal

2021-08-27

Documents

3931 pakuotes lapelis_2021-08-27.docx

Tobramycin VVB_LT_112_DC_ AR.pdf

3931 Tobramycin Via pharma_perr2021-08-27.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

LT/H/0112/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Vienadozėje ampulėje (5 ml tirpalo) yra:	5 ml
Tobramicinas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
59123	73344	1073344	ampulė	5 ml N56		Receptinis	LT/1/16/3931/001	Netiekiama	2024-11-04	2025-12-31	Yes	2024-11-07	2025-12-31	Download

Stadijos

Data	Stadija
2021-08-27	Perregistruotas
2016-06-17	Registruotas